A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid

Journal of Laboratory and Clinical Medicine

Volumn 146, Issue 1, 2005, Pages 30-35

  Carroll, Roger C ^a   Craft, Robert M ^b   Chavez, Jack J ^b   Snider, Carolyn C ^b   Bresee, Stuart J ^b   Cohen, Eli ^b  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; THROMBOXANE; THROMBOXANE B2; THROMBOXANE RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; ASSAY; BLOOD ANALYSIS; BLOOD CELL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; GENERAL SURGERY; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS; INTERMETHOD COMPARISON; LEUKOCYTE; MAJOR CLINICAL STUDY; MONITORING; PATIENT; STEROID THERAPY; SURGICAL PATIENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOELASTOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IBUPROFEN; PLATELET ACTIVATION; PLATELET AGGREGATION; PYRAZOLES; SULFONAMIDES; THROMBELASTOGRAPHY;

EID: 22144435113     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.03.014     Document Type: Article

References (19)

1. J. Maclouf, G. Folco, C. Patrono Eicosanoids and iso-eicosanoids constitutive, inducible and transcellular biosynthesis in vascular disease Thromb Haemost 79 1998 691 705
2. C. Patrono, B. Coller, J.E. Dalen, G.A. FitzGerald, V. Fuster, M. Gent Platelet-active drugs the relationships among dose, effectiveness, and side effects Chest 119 suppl 2001 39S 63S
3. M.R. Buchanan, S.J. Brister Individual variation in the effects of ASA on platelet function implications for the use of ASA clinically Can J Cardiol 11 1995 221 227
4. S. Cortelazzo, M. Marchetti, E. Orlando, A. Falanga, T. Barbui, M.R. Buchanan Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway role of the lipoxygenase pathway Am J Hematol 57 1998 277 282
5. F. Cipollone, P. Patrignani, A. Greco, M.R. Panara, R. Padovano, F. Cuccurullo Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina Circulation 96 1997 1109 1116
6. F. Cipollone, G. Ciabattoni, P. Patrignani, M. Pasquale, D. Di Gregorio, T. Bucciarelli Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina Circulation 102 2000 1007 1013
7. N. Li, H. Hu, M. Lindqvist, E. Wikstrom-Jonsson, A.H. Goodall, P. Hjemdahl Platelet-leukocyte cross-talk in whole blood Arterioscler Thromb Vasc Biol 20 2000 2702 2708
8. R.M. Craft, J.J. Chavez, S.J. Bresee, D.C. Wortham, E. Cohen, R.C. Carroll A novel modification of the Thrombelastograph assay, isolating platelet function, correlated with optical platelet aggregation J Lab Clin Med 143 2004 301 309
9. G.V.R. Born Quantitative investigation into the aggregation of blood platelets J Physiol 16 1962 67 68
10. A. Van Hecken, M.L. Juliano, M. Depre, I. De Lepeleire, J. Arnout, A. Dynder Effects of enteric-coated, low-dose aspirin on parameters of platelet function Aliment Pharmacol Ther 16 2002 1683 1688
11. T.D. Penning, J.J. Talley, S.R. Bertenshaw, J.S. Carter, P.W. Collins, S. Docter Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib) J Med Chem 40 1997 1347 1365
12. B.F. McAdam, F. Catella-Lawson, I.A. Mardini, S. Kapoor, J.A. Lawson, G.A. FitzGerald Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2 the human pharmacology of a selective inhibitor of COX-2 Proc Natl Acad Sci USA 96 1999 272 277
13. H. Salari, P. Braquet, P. Borgeat Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets Prostaglandins Leukot Med 13 1984 53 60
14. W.C. Hope, A.F. Welton, C. Fiedler-Nagy, C. Batula-Bernardo, J.W. Coffey In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin Biochem Pharmacol 15 1983 367 371
15. C.M. Helgason, K.M. Bolin, J.A. Hoff, S.R. Winkler, A. Mangat, K.L. Tortorice Development of aspirin resistance in persons with previous ischemic stroke Stroke 25 1994 2331 2336
16. P.A. Gum, K. Kottke-Marchant, E.D. Poggio, H. Gurm, P.A. Welsh, L. Brooks Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235
17. W.H. Chen, P.Y. Lee, W. Ng, H.F. Tse, C.P. Lau Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J Am Coll Cardiol 43 2004 1122 1126
18. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655
19. A.J. Marcus, M.J. Broekman, D.J. Pinsky COX inhibitors and thromboregulation N Engl J Med 347 2002 1025 1026